21 May 2013
Keywords: astellas, acclerates, cardiome, 10m, fee, japan-based, drug
Article | 17 July 2006
Japan-based drug major Astellas has amended its agreement with Canada's Cardiome over their planned re-submission of the New Drug Application
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 July 2006
20 May 2013
© 2013 thepharmaletter.com